| Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of … T Vos, C Allen, M Arora, RM Barber, ZA Bhutta, A Brown, A Carter, ... The lancet 388 (10053), 1545-1602, 2016 | 6754* | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the … T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1211-1259, 2017 | 6352 | 2017 |
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global … H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta, A Carter, DC Casey, ... The lancet 388 (10053), 1459-1544, 2016 | 5424 | 2016 |
| Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ... The lancet 390 (10100), 1151-1210, 2017 | 5035 | 2017 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3831 | 2018 |
| Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo‐controlled trial JS Bajaj, NH Salzman, C Acharya, RK Sterling, MB White, EA Gavis, ... Hepatology 70 (5), 1690-1703, 2019 | 303 | 2019 |
| Donor screening for fecal microbiota transplantation Z Kassam, N Dubois, B Ramakrishna, K Ling, T Qazi, M Smith, CR Kelly, ... New England Journal of Medicine 381 (21), 2070-2072, 2019 | 139 | 2019 |
| Shiga Toxin–Producing Escherichia coli Transmission via Fecal Microbiota Transplant C Zellmer, MRA Sater, MH Huntley, M Osman, SW Olesen, ... Clinical Infectious Diseases 72 (11), e876-e880, 2021 | 96 | 2021 |
| Fecal microbiota transplantation in HIV: A pilot placebo-controlled study S Serrano-Villar, A Talavera-Rodríguez, MJ Gosalbes, N Madrid, ... Nature Communications 12 (1), 1139, 2021 | 82 | 2021 |
| The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection JR Allegretti, Z Kassam, M Osman, S Budree, M Fischer, CR Kelly Gastrointestinal endoscopy 87 (1), 18-29, 2018 | 67 | 2018 |
| Reaching youth with out-of-facility HIV and reproductive health services: a systematic review DM Denno, V Chandra-Mouli, M Osman Journal of Adolescent Health 51 (2), 106-121, 2012 | 67 | 2012 |
| Scaling safe access to fecal microbiota transplantation: past, present, and future P Panchal, S Budree, A Scheeler, G Medina, M Seng, WF Wong, R Eliott, ... Current gastroenterology reports 20, 1-11, 2018 | 60 | 2018 |
| Framework for rational donor selection in fecal microbiota transplant clinical trials C Duvallet, C Zellmer, P Panchal, S Budree, M Osman, EJ Alm PLoS One 14 (10), e0222881, 2019 | 57 | 2019 |
| Effectiveness and safety of fecal microbiota transplantation for Clostridioides difficile infection: results from a 5344-patient cohort study M Osman, S Budree, CR Kelly, P Panchal, JR Allegretti, Z Kassam, ... Gastroenterology 163 (1), 319-322, 2022 | 35 | 2022 |
| Donor Efficacy in Fecal Microbiota Transplantation for Recurrent Clostridium difficile: Evidence From a 1,999-Patient Cohort M Osman, Z Stoltzner, K O'Brien, K Ling, E Koelsch, N Dubois, ... Open Forum Infectious Diseases 3 (suppl_1), 841, 2016 | 35 | 2016 |
| Prospective assessment of donor eligibility for fecal microbiota transplantation at a public stool bank: results from the evaluation of 1387 candidate donors N Dubois, K Ling, M Osman, L Burns, G Mendolia, D Blackler, J Burgess, ... Open Forum Infectious Diseases 2 (suppl_1), 962, 2015 | 31 | 2015 |
| Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection From An International Public Stool Bank: Results From a 2050 … M Osman, K O'brien, Z Stoltzner, K Ling, E Koelsch, N Dubois, A Khoiri, ... Open Forum Infectious Diseases 3 (suppl_1), 2120, 2016 | 30 | 2016 |
| Stool processing speed and storage duration do not impact the clinical effectiveness of fecal microbiota transplantation JR Allegretti, RJ Elliott, A Ladha, M Njenga, K Warren, K O’Brien, ... Gut microbes 11 (6), 1806-1808, 2020 | 26 | 2020 |
| Global disparities in faecal microbiota transplantation research SW Olesen, P Panchal, J Chen, S Budree, M Osman The Lancet Gastroenterology & Hepatology 5 (3), 241, 2020 | 24 | 2020 |
| Effectiveness of vergence/accommodative therapy for accommodative dysfunction in children with convergence insufficiency AM Chen, TL Roberts, SA Cotter, MT Kulp, LT Sinnott, EJ Borsting, ... Ophthalmic and Physiological Optics 41 (1), 21-32, 2021 | 21 | 2021 |